Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FNMXL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,043
Award facts
- Contract value 100% obligated
- $10,042.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, represents a direct pharmaceutical supply fulfillment to support Department of Defense medical facilities. The award carries no set-aside designation, demonstrating the contractor's competitive standing in federal procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. This IDC framework enables the agency to procure an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group has consistently delivered specialized medical products ranging from oncology treatments to injectable medications to defense healthcare systems across the nation.
Quick answers
Who was awarded contract SPE2DB25FNMXL?
SPE2DB25FNMXL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FNMXL worth?
The government has obligated $10,043 on SPE2DB25FNMXL.
Is contract SPE2DB25FNMXL an order under another contract?
Yes. SPE2DB25FNMXL is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMXL competed?
The extent of competition for SPE2DB25FNMXL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award